Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Kentucky Wildcats topple Duke Blue Devils 77-72 in hard-fought battle
Program
Frosty front lawns in the morning. Where temperatures fall overnight and when we get a chilly dose of rain
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Aduhelm
Recent news which mentions Aduhelm
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
Aduhelm
ESALY
Benzinga
From
Benzinga
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
Health Care
Aduhelm
Benzinga
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
News
Alzheimer’s
Health Care
From
Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
September 23, 2021
Tickers
BIIB
Tags
Price Target
Aduhelm
Alzheimer's disease
From
Benzinga
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
July 27, 2021
Tickers
BIIB
IONS
Tags
Biotech
Alzheimer's disease
Benzinga
From
Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
July 27, 2021
Tickers
BIIB
ESALF
ESALY
Tags
News
Briefs
Biotech
From
Benzinga
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
July 15, 2021
Tickers
BIIB
Tags
BIIB
Market News
Short Ideas
From
Benzinga
FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval
July 09, 2021
Tickers
BIIB
Tags
FDA
BIIB
General
From
Benzinga
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
July 08, 2021
Tickers
BIIB
ESALY
Tags
alzheimer's
FDA
General
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.